SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-077850
Filing Date
2024-06-26
Accepted
2024-06-26 16:05:05
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 5 ownership.html 5  
1 5 ownership.xml 5 4175
  Complete submission text file 0000950170-24-077850.txt   5644
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MERUS N.V. VALELAAN 62 UTRECHT P7 3584 CM
Business Address
Shuman Harry (Reporting) CIK: 0001791115 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37773 | Film No.: 241073429